Pall inks $7m deal with Exothera for suspension based production of viral vectors
Filtration, separation and purification specialist, Pall, has announced a new contract valued at over US$7M with full-service CDMO, Exothera.
Archives for July 19, 2021
NPD Gallery: Technology Insider
We report on some of the latest biopharma industry targeted new releases in terms of technological innovation.
Celltrion: COVID-19 antibody treatment effective against Delta variant
Celltrion Group has reported that data from an in vivo efficacy study shows that its monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59), has a strong neutralizing effect against the rapidly spreading Delta variant.
GentiBio and Forge Biologics in viral vector contract development and GMP manufacturing partnership
Boston headquartered biotherapeutics company, GentiBio, Inc, and CGT focused CDMO, Forge Biologics, have set up a development and manufacturing partnership.
FDA grants priority review for Pfizer COVID-19 vaccine BLA
The US Food and Drug Administration (FDA) has granted priority review designation for Pfizer and BioNTech’s COVID-19 vaccine Biologics License Application (BLA).
GSK reveals plans for one of Europe’s largest life science campuses
GSK has set out a vision for a new campus in Stevenage, UK: which could create up to 5,000 jobs over the next decade.